Intercept Pharmaceuticals, Inc.: cash_and_restricted_cash

Value{"amount": 103656000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2023-09-30)
Statuscurrent
EntityIntercept Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-23-017790 · Open the official SEC filing →
Retrieved: 2026-08-19T12:06:49.834115+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001270073/cash-and-restricted-cash/2023-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/8a59b1d7-bd67-46de-b682-11ecb9dfea9e

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies